Title |
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis |
|---|---|
Involved |
Mike Wenzel (Verfasser)
Luigi Nocera (Verfasser) Claudia Collà Ruvolo (Verfasser) Christoph Würnschimmel (Verfasser)
Zhe Tian (Verfasser)
Shahrokh F. Shariat (Verfasser) Fred Saad (Verfasser) Derya Tilki (Verfasser) Markus Graefen (Verfasser) Luis Kluth (Verfasser) Alberto Briganti (Verfasser) Philipp Mandel (Verfasser) Francesco Montorsi (Verfasser) Felix Chun (Verfasser) Pierre I. Karakiewicz (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Prostate cancer and prostatic diseases 25, 2, 30.5.2021, date:6.2022, Seite 139-148 |
Published |
2021 |
Language |
|
Country |
|
Topic |
|
Subject |
Biomedicine, general. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2022082321063896180286 (URN) |
Record ID |
1266168672 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: